- Case report
- Open Access
- Open Peer Review
This article has Open Peer Review reports available.
Post-menopausal vaginal bleeding caused by carcinoma of the appendix: a case report
© van Huisseling et al; licensee BioMed Central Ltd. 2010
Received: 2 November 2008
Accepted: 2 May 2010
Published: 2 May 2010
Post-menopausal blood loss is a common complaint of patients seen in gynecological practice. The most frequent malignancy found in cases of post-menopausal bleeding is endometrial cancer. Other causes can be malignancies of the rest of a woman's genital tract or metastases from other tumors. To the best of our knowledge, it appears that this is the first published case of a post-menopausal primary appendiceal carcinoma presenting with vaginal blood loss.
A 75-year-old Caucasian woman with a history of vaginal hysterectomy presented with a 10-month history of post-menopausal blood loss. After extensive examination and discussion, ovarian carcinoma was suggested. Microscopic examination of the tissue removed at laparotomy revealed an adenocarcinoma of the appendix. She was treated with adjuvant radiotherapy and with palliative chemotherapy after 14 months because of intra-abdominal metastatic disease.
Post-menopausal blood loss in a patient with a history of hysterectomy is uncommon and always needs further investigation.
Post-menopausal blood loss is a common complaint of patients seen in gynecological practice. The most frequent malignancy found in cases of post-menopausal bleeding is endometrial cancer. Other causes of malignant post-menopausal blood loss can be carcinomas of a woman's genital tract (vagina, cervix, fallopian tubes or ovaries) or metastases from other tumors [1, 2]. Post-menopausal bleeding with a history of hysterectomy is rather uncommon. We present a case of post-menopausal blood loss in a hysterectomized patient caused by carcinoma of the appendix.
To the best of our knowledge, it appears that this is the first case of a post-menopausal primary appendiceal carcinoma presenting with vaginal blood loss.
A 75-year-old Caucasian woman was referred to our hospital with a 10-month history of vaginal bleeding. In 1986, she underwent a hysterectomy because of dysfunctional uterine bleeding. The cause of the blood loss was initially interpreted as vaginal atrophy which was unsuccessfully treated with estriol cream. She had experienced several urinary tract infections, which she never had before. She did not have any other complaints.
On physical examination, it was found that there was no palpable abdominal mass. On vaginal examination, a crater-shaped lesion was found in the right upper part of the vagina, which indurated the surrounding tissue, with a fetid smell and necrosis. Rectal examination showed no abnormalities.
Transvaginal ultrasound showed a 30 × 22 mm tumor on the top of the vagina. No ascites were seen. A biopsy revealed an adenocarcinoma. Immunohistochemical staining was positive for cytokeratin 20 and carcinoembryonic antigen (CEA), and negative for cytokeratin 7 and carbohydrate antigen (CA)-125, suggesting the origin of the tumor was more likely to be gastrointestinal than urogenital.
Laboratory findings, including tumor markers, were all within normal values, except for CEA (Immulite 2500, Siemens Medical Solution Diagnostics, LA, USA), which was raised at 16 μg/L (normal 2-4 μg/L).
During laparotomy, it was observed that the vaginal vault was infiltrated by an enlarged tumorous appendix, with two loops of the ileum attached to the process. No infiltration in the bladder was seen. A right hemicolectomy was performed on part of the upper vagina. Both ovaries had a normal atrophic aspect.
Fourteen months after surgery, during a transvaginal ultrasound in a regular follow-up, the tumor was found to have recurred. Ascites were also seen. Abdominal and pelvic CT scans revealed extensive intra-abdominal tumor spread with deposits on the diaphragm, omentum, vaginal vault and the sigmoid colon.
The multidisciplinary oncology team advised palliative treatment with the combination oxaliplatin-capecitabine, as the tumor was colon-like. After three cycles of chemotherapy, CA-125 levels decreased from 162 to 86 kU/L (Immulite 2500) and a CT scan showed significant reduction of the tumor deposits.
Post-menopausal vaginal bleeding is a common complaint of patients seen in gynecological practice. It accounts for approximately 5% of all gynecological visits . Every case of post-menopausal bleeding is abnormal and should be investigated for any malignancy until proven otherwise [1, 4]. The most frequent malignancy found in cases of post-menopausal bleeding is endometrial cancer. However, our patient had a hysterectomy in 1986. In our case, the vaginal examination was sufficient to suggest a malignant cause for the vaginal bleeding, because of the crater-shaped lesion found, and the indurated and necrotic tissue.
Primary carcinoma of the vagina is rare. It represents only 2% of all gynecological malignancies . Most of these tumors are found in patients whose mothers used diethylstilbestrol (DES) during pregnancy. About 0.1% of prenatal exposed women develop vaginal carcinomas . Since DES was prescribed to pregnant women from 1947 to 1976 in The Netherlands, our patient was too old to be a so-called 'DES daughter'.
The differential diagnosis included metastasis from an unknown primary tumor, carcinoma of the ovary and an intestinal tumor with infiltration in the vagina. Our patient had no complaints that suggested malignancy of the colon. Furthermore a colonoscopy showed no abnormalities. A recent mammogram was also normal. Only the raised level of CEA was suspicious, as was immunohistochemistry of the biopsies taken, which suggested a gastrointestinal origin for the tumor. During CT scan, a tumor originating from the right ovary was seen, suggesting ovarian carcinoma. However infiltration of ovarian carcinoma in the vagina is rare.
It was unexpected that the tumor had its origin in the appendix. Appendiceal carcinoma is very rare; it has an incidence of 0.12 cases per 1,000,000 people per year . Primary malignant tumors of the appendix only account for less than 0.5% of all intestinal tumors. Primary appendiceal malignancies are classified into three types: carcinoid tumors, mucinous cystadenocarcinomas and adenocarcinomas. Primary adenocarcinomas of the appendix are approximately 10 times less common than appendiceal carcinoids .
Mostly appendiceal carcinomas present with acute right lower abdominal pain suggestive of appendicitis. Appendiceal carcinoma can also present as a palpable abdominal mass, acute intestinal obstruction or ascites. Most appendiceal malignancies are diagnosed from histological analysis of surgically removed specimens after a simple appendectomy [8, 9].
Our patient's previous hysterectomy probably allowed the tip of the appendix to move near to the vaginal vault thus causing the infiltration. Fourteen months after the initial diagnosis, our patient had recurrent disease with peritoneal carcinomatosis. The prognosis of peritoneal carcinomatosis of colorectal origin can be improved by peritonectomy followed by hyperthermic intraperitoneal chemotherapy, although this option was not considered appropriate for our patient because of her physical condition and the high morbidity and mortality risk of the procedure .
In one previous case report, a patient with an appendiceal carcinoma presented with post-menopausal blood loss which was caused by a metastatic tumor affecting the uterus, fallopian tubes, ovaries and peritoneal cavity .
Post-menopausal bleeding in a patient with a history of hysterectomy is uncommon. This case highlights the need to conduct careful examination of a patient to exclude the possible non-gynecological origin of vaginal bleeding.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Dutch Society of Obstetrics and Gynaecology (NVOG).http://nvog-documenten.nl/index.php?pagina=/richtlijn/pagina.php&fSelectTG_62=75&fSelectedSub=62&fSelectedParent=75
- Dijkwel GA, van Huisseling JCM: Two post-menopausal women with vaginal bleeding due to non-gynaecological malignancies. Ned Tijdschr Geneeskd. 2005, 149: 2649-2652.PubMedGoogle Scholar
- Medverd JR, Dubinsky TJ: Cost analysis model: US versus endometrial biopsy in evaluation of peri- and postmenopausal abnormal vaginal bleeding. Radiology. 2002, 222: 619-627. 10.1148/radiol.2223001822.View ArticlePubMedGoogle Scholar
- Brenner PF: Differential diagnosis of abnormal uterine bleeding. Am J Obstet Gynecol. 1996, 175: 766-769. 10.1016/S0002-9378(96)80082-2.View ArticlePubMedGoogle Scholar
- Heller DS, Kambham N, Smith D, Cracchiolo B: Recurrence of gynecologic malignancy at the vaginal vault after hysterectomy. Int J Gynaecol Obstet. 1999, 64: 159-162. 10.1016/S0020-7292(98)00245-8.View ArticlePubMedGoogle Scholar
- Swan SH: Intrauterine exposure to diethylstilbestrol: long-term effects in humans. APMIS. 2000, 108: 793-804. 10.1111/j.1600-0463.2000.tb00001.x.View ArticlePubMedGoogle Scholar
- McCusker ME, Cote TR, Clegg LX, Sobin LH: Primary malignant neoplasms of the appendix. Cancer. 2002, 94: 3307-3312. 10.1002/cncr.10589.View ArticlePubMedGoogle Scholar
- Lyss AP: Appendiceal malignancies. Semin Oncol. 1988, 15: 129-137.PubMedGoogle Scholar
- Tucker ON, Madhavan P, Healy V, Jeffers M, Keane FBV: Unusual presentation of an appendiceal malignancy. Int Surg. 2006, 91: 57-60.PubMedGoogle Scholar
- Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H: 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008, 15 (9): 2426-2432. 10.1245/s10434-008-9966-2.View ArticlePubMedGoogle Scholar
- Alenghat E, Talerman A, Path FRC: Adenocarcinoma of the vermiform appendix presenting as a uterine tumor. Gynecol Oncol. 1982, 13: 265-268. 10.1016/0090-8258(82)90038-5.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.